Related Experiment Video
Updated: Jun 12, 2026

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
Published on: December 3, 2016
Growth patterns and the use of growth hormone in the mucopolysaccharidoses
1University of Minnesota, Department of Pediatrics, Division of Endocrinology, Minneapolis, MN, USA.
Insights
Short stature is common in mucopolysaccharidosis (MPS). This review examines growth patterns and treatment impacts, including human growth hormone (hGH), for children with MPS.
Area of Science:
- Pediatrics
- Genetics
- Endocrinology
Background:
- Short stature is a hallmark of mucopolysaccharidosis (MPS) diseases.
- Understanding natural growth patterns in MPS is crucial for managing skeletal dysplasias.
- Current treatments like hematopoietic cell transplantation (HCT) and enzyme replacement therapy (ERT) have unknown long-term effects on growth.
Purpose of the Study:
- To review published data on growth in children with MPS.
- To describe preliminary data on human growth hormone (hGH) use in MPS patients.
- To provide insights for individualized growth-promoting treatment decisions.
Main Methods:
- Literature review of published growth data in MPS.
- Analysis of preliminary data on hGH treatment in MPS.
- Synthesis of information on growth patterns and treatment outcomes.
Main Results:
- Published data on growth in MPS diseases is reviewed.
- Preliminary findings on hGH therapy in MPS are presented.
- The long-term impact of HCT and ERT on MPS growth remains under investigation.
Conclusions:
- Accurate growth data is essential for MPS patient care.
- hGH may offer potential for growth promotion in MPS, requiring further study.
- Individualized treatment strategies are key for optimizing growth in children with MPS.
Abstract:
Short stature is characteristic of patients with mucopolysaccharidosis (MPS) diseases. For children with skeletal dysplasias, such as MPS, it is important to know the natural history of growth. An understanding of the natural growth pattern in each MPS disease provides a measurement to which treatments can be compared, as well as data which can help families and providers make individualized decisions about growth promoting treatments. Multiple advancements have been made in the treatment of MPS with both hematopoietic cell transplantation (HCT) and enzyme replacement therapy (ERT). The long term benefit of these treatments on growth is unknown. This article will review the published data on growth in children with MPS, and describe preliminary data on the use of human growth hormone (hGH) in children with MPS.
Related Concept Videos
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Biosynthesis of Polysaccharides
Growth of Cartilage and Bone Tissue
